Nautilus Biotechnolgy
NAUT
NAUT
81 hedge funds and large institutions have $211M invested in Nautilus Biotechnolgy in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.31% less ownership
Funds ownership: 46.25% → 42.94% (-3.3%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
81
Holding in Top 10
2
Calls
$261K
Puts
–
Top Buyers
| 1 | +$5.72M | |
| 2 | +$623K | |
| 3 | +$498K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$318K |
| 5 |
CAM
Crown Advisors Management
Larkspur,
California
|
+$246K |
Top Sellers
| 1 | -$494K | |
| 2 | -$356K | |
| 3 | -$282K | |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$197K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$170K |
